BioMedWire Stocks Archives - BioMedWire (BMW)

FridayApr 24, 2026 10:00 am

Survey Finds That American Adults Want Health Inequities Eliminated

Last fall, Johns Hopkins School of Nursing through its Institute for Policy Solutions conducted a survey on health inequities and the full report from that survey was released weeks ago. The findings of that poll offer valuable insights that policymakers and all stakeholders need to weigh while making decisions impacting the health of Americans. The majority (70%) of the respondents say health care is a right and that it shouldn’t be treated as a privilege. The survey found that while there is a sense that Americans are heavily polarized on national issues, this isn’t the case when it comes to matters of health care. Notably, 62% of those who participated in the survey revealed…

ThursdayApr 23, 2026 10:00 am

New Urine Test Could Predict Response to Bladder Cancer Treatment

Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has residual bladder cancer after they have undergone surgery to remove the tumor. This test may also detect whether immunotherapy treatment administered after surgery has been effective or residual bladder cancer remains. The study containing those findings appeared in the journal Cell. If this urine test is successfully validated in larger clinical trials, it could mark a major shift in the way bladder cancer is treated. Conventionally, bladder cancer is monitored by obtaining a tissue sample for molecular analysis. This approach is costly and subjects patients to several invasive procedures. With this new test, all a…

TuesdayApr 21, 2026 10:00 am

Why Molecular Testing is Increasingly Important in CNS Cancers

Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity, and these tumors can be hard to identify using traditional imaging or histopathology analysis. Molecular analysis has emerged as a major way to identify these tumors and help medical teams plan how best to help those diagnosed with these cancers. Biomarker testing is a growing field that is making it possible for the molecular structure of CNS cancers to be analyzed for not only diagnostic purposes but also other functions as well. Recent advances like the detection of tumor RNA particles in blood samples now mean that a brain cancer can be identified and tracked without subjecting patients to…

FridayApr 17, 2026 10:00 am

Americans are Supplementing Healthcare Visits with AI, Gallup Survey Finds

A survey that was conducted toward the end of last year by Gallup and West Health found that a sizeable number of Americans are using AI to supplement their interactions with healthcare providers. However, the specifics of how people used these digital tools varied based on age groups, income level and motivations. The survey was carried out from October 27 to December 22 in 2025. A total of 5,500 adults participated in the poll that was designed to be nationally representative. Among those who had used AI in the last 30 days, 59% said they used AI tools to conduct research on their own prior to visiting their doctor.…

ThursdayApr 16, 2026 10:00 am

New AI Tool Could Boost the Early Detection of Lung Cancer

Lung cancer is the leading cause of cancer-linked fatalities among men and women, and survival beyond five years post-diagnosis is minimal. This is largely because most cases are detected when they are already advanced. Scientists are therefore searching for ways to boost early detection so that treatment outcomes can improve and survival can increase. A new study seems to have found a way to use AI to improve the early detection of this disease. This tool could be especially helpful in flagging lung cancer when tumors are still small and are harder to detect using the existing diagnostic tools. These existing tools, such as CT scans, have…

TuesdayApr 14, 2026 10:00 am

Preclinical Study Reveals Promising Treatment for Glioblastoma

Glioblastoma is a deadly type of brain cancer which progresses rapidly and kills victims within months. For nearly two decades, no significant progress has been made in developing an effective treatment against this malignancy. Now, a new preclinical study using animal models has unveiled a potential breakthrough that could eliminate these tumors. The study, whose findings were published in the journal Nature, was conducted by scientists at the startup Trogenix. The team is made up of scientists at the Cancer Institute at University College London, the Royal Infirmary at Edinburgh, and the University of Edinburgh. The team developed SSEs technology (Synthetic Super-Enhancers) that entails using a viral vector to carry genetic instructions into glioblastoma tumors. The genetic instructions…

FridayApr 10, 2026 10:00 am

Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA

The immune system is capable of identifying and attacking cancer cells in the body. This process depends on the tumor producing damaged RNA, which then sticks to cell surfaces and provides the antigens that the body identifies as foreign and therefore targets. However, a natural mechanism within the body that removes faulty RNA ironically aids many cancers to avoid detection and therefore limit immune system responses to the disease. Now, a new preclinical study has found that targeting and blocking this clean-up mechanism can allow cancer antigens to express on tumor cells and allow the immune system to quickly identify and attack them. The study was conducted by a University…

ThursdayApr 09, 2026 10:00 am

Shares of Health Insurers Rally After CMS Bumps Up 2027 Rates

The shares of health insurers in the U.S. recorded gains after the Trump administration announced 2027 payment rate increases for Medicare Advantage that were higher than what had been proposed back in January. That improved rate would increase payments to these firms by about $13bn in the coming fiscal year 2027. In January when the federal government revealed that it would be increasing these payments by 0.09%, the insurance firms took a hit to their stock prices because this rate was much lower than had been expected. Investors viewed that small increase as additional pressure on already tight margins, but the surprise announcement of about 2.8% extra payments to MA firms covering older…

TuesdayApr 07, 2026 10:00 am

Study Explores Whether a Common Vitamin Could Fight Brain Cancer

Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds promise in restoring immune function in the fight against glioblastoma, a brain cancer that grows aggressively and is hard to treat. For over two decades, no significant advancement has been made to improve treatment outcomes in patients with glioblastoma. Treatments like radiation, surgery and chemotherapy help, but the tumors regrow and survival times are dismal. The team at the University of Calgary wanted to establish whether vitamin B3 in high doses may boost treatment outcomes when used alongside current treatment approaches. The scientists want to find out whether this…

MondayApr 06, 2026 10:00 am

Gallup Poll: Healthcare Returns to the Top of Americans’ Biggest Domestic Worries

According to a poll conducted by Gallup in March, Americans are most concerned about healthcare. This finding is notable given the escalation in the Iran war and the way events in the Middle East are currently dominating news headlines. Gallup conducted a poll seeking the views of Americans about how much they worry about a list of 15 policy areas on the domestic front. 61% of the respondents revealed that they are greatly worried about healthcare. The next four biggest sources of worry for Americans were connected to economic issues. Those policy issues are the state of the economy, concerns about inflation in the country, spending by…